See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← ALENO page
XStocksXray
Market X-Ray report · 23 October 2026

Enogia SAS (ALENO)

Euronext Paris · France · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 5.740
52-week range3.840 – 7.200
Return, 1 month / 3 months−9.2% / −9.2%
Return, 1 year / 3 years+26.4% / +228.9%
TrendBelow its 200-day average
RSI (14)40
Volatility (1 year)39.9%
Worst drawdown (1 year)-22.0%
Average daily value traded0.03M EUR
Dividend yield–

Market X-Ray price-based

64/ 100 · High confidence · ahead of 72% of stocks on this exchange
Trend68
Momentum67
Stability (higher is calmer)64
Liquidity50
Income–

Five-year price chart navy: price · brown: 200-day average

1.053.185.317.449.572021-112023-022024-052025-082026-10

About the company

Enogia SAS is a French engineering company based in Marseille that designs and makes small turbomachinery for converting heat into electricity. Its main products are compact organic Rankine cycle systems and high-speed turbines, which recover waste heat from engines, industrial processes and other sources and turn it into usable power. Customers include industrial operators, engine and equipment manufacturers, and businesses looking to generate electricity from heat that would otherwise be lost.

Enogia SAS trades under the code ALENO on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Enogia SAS (ALENO) trades on the Euronext Paris in France. It last closed at EUR 5.740 on 23 October 2026.

Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 178 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 26.4% and over the last three months it fell 9.2%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Enogia SAS (ALENO)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend68 · FairMixed trend against its averages.
Above 200-day average-6.5%
From 52-week high-16.8%
Momentum67 · FairTypical recent returns for this exchange.
3-month return-9.2%
6-month return-4.3%
12-month return, skipping the last month39.2%
Stability (higher is calmer)64 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)39.9%
Worst drawdown, 1 year (smaller is calmer)-22.0%
Liquidity50 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.03M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−2.7%
1 month−9.2%
3 months−9.2%
6 months−4.3%
1 year+26.4%
3 years+228.9%
5 years−29.0%

Signals

50-day / 200-day average6.236 / 6.139
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.155

Technical summary

DailyStrongly bearish1 bullish · 4 neutral · 11 bearish
WeeklyBearish3 bullish · 1 neutral · 8 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026